{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-007260","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2024-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.714897+00:00","generated_at":"2026-06-01T06:51:34.902636+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CEO loans Catheter Precision $500K at 8%; enters royalty agreement for LockeT device","bullets":["CEO David Jenkins loaned $500,000 via 8% promissory note due August 30, 2024.","Royalty agreement with co-inventor Auston Locke: 5% net sales of LockeT device until $1M, then 2% up to $10M; ends Dec 31, 2033 or patent expiry.","Jenkins and affiliates hold >10% common stock, Series X preferred convertible into >8M shares, and 11.77% royalty on LockeT sales.","Missiaen Huck, Jenkins' adult daughter, serves as non-executive COO."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-007260","json":"https://secwatch.observer/filing/0001654954-24-007260.json","markdown":"https://secwatch.observer/filing/0001654954-24-007260.md","text":"https://secwatch.observer/filing/0001654954-24-007260.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000165495424007260/0001654954-24-007260-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000165495424007260/rmed_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:51:34.902636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}